๐๐ผ๐ ๐ฑ๐ผ ๐ฏ๐ฟ๐ฎ๐ถ๐ป ๐ฎ๐ฟ๐ฒ๐ฎ๐ ๐ฟ๐ฒ๐น๐ฎ๐๐ฒ๐ฑ ๐๐ผ ๐ณ๐๐ป๐ฐ๐๐ถ๐ผ๐ป?
"High-resolution activity maps of PFC did NOT align with cytoarchitecturally defined subregions."
Key tenet in neuroscience is that cytoarchitectonic boundaries correspond to functional ones.
NB: study in the mouse
#neuroskyence
doi.org/10.1038/s415...
22.01.2026 17:34 โ ๐ 80 ๐ 29 ๐ฌ 6 ๐ 3
Please use full factorial designs in preclinical psychedelic research! I'm guilty of not doing so in the past, but it will be critical for understanding their MOA going forward. We need to be able to directly compare effects in pathology to those healthy organisms
23.01.2026 16:29 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0
Excellent interview... VERY interesting insights on stress vs mitochodrial energy balance. I wonder how much impact on stress adaptation can be gained by increasing mitochondrial resilience w keto/low carb/ Fasting and the right amount of Exercise stress (hiit, resistance trng)
27.12.2025 23:13 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0
YouTube video by Metabolic Mind
Could Stress Be The Hidden Driver of Mental Illness?
I had a fantastic discussion about our Allostatic Triage Model of Psychopathology (ATP Model) and the potential mitochondrial and metabolic effects of psychedelics with @metabolicmind.bsky.social
Thanks so much for having me on!
Check er out:
youtu.be/-e49-DwCZ9A?...
10.12.2025 20:10 โ ๐ 6 ๐ 3 ๐ฌ 4 ๐ 0
Congrats @carmensandi10.bsky.social !!
06.11.2025 16:53 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Population norms. The average rate of neurodegenerative disease in the general population.
03.11.2025 19:59 โ ๐ 4 ๐ 0 ๐ฌ 0 ๐ 0
Posted the paper above
03.11.2025 15:55 โ ๐ 3 ๐ 0 ๐ฌ 1 ๐ 0
I posted the paper above
03.11.2025 15:55 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
ADHD increases dementia risk, but the available epidemiological data suggests that stimulant medications may normalize risk. Totally fascinating
Thanks @hologramvin.bsky.social for this post! I did not know this so I hunted down the original paper:
jamanetwork.com/journals/jam...
03.11.2025 15:54 โ ๐ 67 ๐ 27 ๐ฌ 1 ๐ 8
Totally understandable and no worries at all. Thank you for the response. Iโll keep looking
03.11.2025 15:39 โ ๐ 2 ๐ 0 ๐ฌ 1 ๐ 0
Cool article. Not my field, so grain of salt, but regarding the cognitive benefits, I believe people need to take at least 5-10+ grams per day to significantly increase creatine concentrations in the brain, so you might not expect to see much change at the 3-5 grams/day recommended in the article.
03.11.2025 15:32 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
Several others have now asked for references here too. Can you at least let us know where you heard this information so that I can try to track it down? Iโm a scientist working partly in neurodegenerative diseases and Iโm particularly curious about this question, and have been for some time
03.11.2025 15:22 โ ๐ 2 ๐ 0 ๐ฌ 1 ๐ 0
Thatโs really interesting. Do you have a reference for that study?
31.10.2025 17:36 โ ๐ 4 ๐ 0 ๐ฌ 0 ๐ 0
Afaik, midazolam is not antidepressant, (but it does induce acute amnesia), begging the question initiated by @theborislab.bsky.social here: pmc.ncbi.nlm.nih.gov/articles/PMC... : are these expectancy effects? you tell someone something will work, they have a drug experience and then feel better?
23.10.2025 16:00 โ ๐ 2 ๐ 0 ๐ฌ 0 ๐ 0
There are at least 2 kinds of active placebos: phenomenological and therapeutic placebos.. do they trick the participant because they feel similar to the active drug or bc they produce therapeutic effects? I am not aware of the antidepressant properties of benzos, so I assumed it was phenom placebo
23.10.2025 15:46 โ ๐ 0 ๐ 0 ๐ฌ 2 ๐ 0
Wait so midazolam is an antidepressant? Wut?
23.10.2025 13:32 โ ๐ 5 ๐ 0 ๐ฌ 2 ๐ 0
Hot off the press!
20.10.2025 19:42 โ ๐ 7 ๐ 2 ๐ฌ 0 ๐ 0
So many thanks to all of my mentors & co-authors for making this possible: @martinpicardenergy.bsky.social @thethrivelab.bsky.social @trpr-ucsf.bsky.social @parkersingleton.bsky.social @curiouslykaty.bsky.social, Gabriel Sturm, Ellen R. Bradley, Thomas Neylan, and Joseph Francis
20.10.2025 17:33 โ ๐ 4 ๐ 0 ๐ฌ 0 ๐ 0
The way we feel and the psychiatric symptoms some of us end up experiencing could emerge from the way energy flows, or fails to flow smoothly, in mitochondria.
The ATP model (Allostatic Triage in Psychopathology) by Parker Kelley @sequencemyneuro.bsky.social
www.sciencedirect.com/science/arti...
17.10.2025 02:42 โ ๐ 6 ๐ 3 ๐ฌ 0 ๐ 0
Altogether, we propose that extreme or chronic stress dysregulates mitochondria, affect, and allostatic triage, impairing allostasis, and driving transdiagnostic pathological states that, over time, become entrenched or "canalized" into pathological transdiagnostic disease phenotypes.
20.10.2025 15:59 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
We propose that metabolic stress drives allostatic triage to stress-responsive networks that ensure short-term survival, like the salience network, from other networks including the central executive network that supports executive and goal-oriented functions, driving psychiatric symptoms
20.10.2025 15:59 โ ๐ 2 ๐ 1 ๐ฌ 1 ๐ 0
What happens when the brain cannot generate enough energy to handle stress?
20.10.2025 15:59 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0
Stress is metabolically expensive & all biology depends on finite energy resources, especially the CNS, which is the most expensive tissue in the body and has limited access to metabolic resources.
20.10.2025 15:59 โ ๐ 2 ๐ 1 ๐ฌ 1 ๐ 0
In the ATP Model, we introduce a novel concept- Allostatic Triage: the stress-induced reallocation of CNS metabolic resources from expensive executive control networks that optimize long term outcomes to less expensive networks optimized for short-term survival, like the salience network
20.10.2025 15:59 โ ๐ 1 ๐ 0 ๐ฌ 1 ๐ 0
๐จPublication alert! ๐จ
Why does stress drive psychopathology & transdiagnostic disease?
We present the Allostatic Triage Model of Psychopathology (ATP Model), which explains stress-induced transdiagnostic disease pathogenesis through a bioenergetic lens.
www.sciencedirect.com/science/arti...
20.10.2025 15:59 โ ๐ 14 ๐ 8 ๐ฌ 5 ๐ 1
Is it really? There are lots of bad therapists, but they nonetheless abide by strict ethical codes. Bad things happen with human therapists for sure, but Iโm not sure weโre at the point in which we can even trust an AI not to hallucinate wildly and encourage patients to destroy their lives
29.08.2025 13:32 โ ๐ 0 ๐ 0 ๐ฌ 1 ๐ 0
I'm near certain sLFOs are big for psychedelics.
26.08.2025 17:14 โ ๐ 4 ๐ 1 ๐ฌ 0 ๐ 0
Just delighted to see this out in the world !! This is the first installment of SYPRES -- our living meta-analysis + open data resource focused on psychedelics. Led by the incomparable @parkersingleton.bsky.social and @bsevchik.bsky.social. Check it out + and give us your feedback!!!
18.08.2025 14:37 โ ๐ 16 ๐ 9 ๐ฌ 0 ๐ 0
Tecnรณlogo Educativo y autor del newsletter El Gerontogamificador (rb.gy/lxc8hk), uno de los principales boletines de tecnologรญa educativa en espaรฑol en LinkedIn. Especializado en AgeTech y temas relacionados. Ex Perplexity AI Business Fellow.
2-D artist, frontend tinkerer, painter at heart, full-time dreamer.
Former grumpy record store guy, turned cognitive scientist, turned research methodologist, turned... well, still working on that part.
Crypto Knight / Blockchain Founder Investor / Emerging Tech Influencer
Full-time RVer! Certified Personal Trainer & Nutritionist, RVT, Retired USN MCPO Aircrew Linguist
Board-certified bodyworker, CE educator, and founder of Unwind, where the body is the guide in psychedelic experiences.
Post-psychedelic integration bodywork, Ketamine-Assisted Therapeutic Myofascial Bodywork.
By referral only.
bio.site/bookunwind
Pain scientist. Asst Clinical prof @ UCSF, lecture @ Stanford. Psychologist. Disruptor. Author๐ Tell Me Where It Hurts. Neuroscience nerd ๐ง #medsky #medtwitter #SciComm #neuroskyence
www.zoffness.com
Brit Col Fascinated with all things psychological. Massive nerd, deeply sensitive, with enormously diverse interests. Volunteering to help with homelessness is a heartfelt passion. 25+yrs. I genuinely believe in dropping judgement and in offering kindness.
Mitochondrial Psychobiology. Bridging the science of energy and the human experience to create Healing Science. Upcoming book: ENERGY (2027).
Professor at Yale School of Medicine; Associate Director of Yale MD/PhD Program; Amateur Perfumer; Retired Attorney; Court-Appointed Special Advocate Volunteer, CASA-NYC. ๐งช๐งช๐งช ๐ฆ
๐ฆ
๐ฆ
๐๐๐
https://medicine.yale.edu/profile/michael-nitabach/
Tryptamine and azobenzene lover
UConn Chemistry
PhDing|Classic & Punk Rock๐ธAngler๐ฃ๐ฆHiker๐ฅพ
PhD Student in the Fadok Lab at Tulane studying the effects of psilocybin on conditioned flight and hyperarousal| ๐ญ๐ณ
Phish enthusiast & behavioral pharmacologist. Allegheny College/NMU/WFU alumn. NIDA F32 Fellow & France Lab postdoc at UT Health San Antonio. science & drug policy advocate. only my opinions (she/her)
Biomedical Engineering Postdoc @ Cornell University | Studying psychedelic drug action in vivo ๐ง ๐
computational affective motivational (neuro)psychiatry. interested in serotonin, stress, & decision-making. K99 Fellow at Brown. https://debyeeneuro.com she/her.
Neuroscience PhD Candidate at McGill University
Researching the neurobiology of stress and novel treatments for psychiatric disorders. Postdoc in the Kwan lab at Cornell. Mental health advocate and level 16 Orc Wizard. He/him.